0.00Open0.05Pre Close0 Volume232 Open Interest10.00Strike Price0.00Turnover48.16%IV14.99%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier17DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1158Delta0.2109Gamma174.80Leverage Ratio-0.0052Theta0.0005Rho20.24Eff Leverage0.0037Vega
Profound Medical Stock Discussion
NEWS
Growing Body of Clinical Evidence Points to the Potential of Profound Medical’s TULSA Procedure Becoming a Mainstream Treatment Modality Across the Entire Prostate Disease Spectrum
Profound Medical Corp.'s TULSA procedure is gaining recognition as a mainstream treatment for prostate diseases, with 25 scientific research presentations this year alone. The clinical evidence showcases TULSA's efficacy in treating a diverse range of patients with localized prostate c...
No comment yet